197 related articles for article (PubMed ID: 31237992)
1. Anticonvulsant Mood Stabilizer and Lithium Use and Risk of Adverse Pregnancy Outcomes.
Cohen JM; Huybrechts KF; Patorno E; Desai RJ; Mogun H; Bateman BT; Hernández-Díaz S
J Clin Psychiatry; 2019 Jun; 80(4):. PubMed ID: 31237992
[TBL] [Abstract][Full Text] [Related]
2. Placental Complications Associated With Psychostimulant Use in Pregnancy.
Cohen JM; Hernández-Díaz S; Bateman BT; Park Y; Desai RJ; Gray KJ; Patorno E; Mogun H; Huybrechts KF
Obstet Gynecol; 2017 Dec; 130(6):1192-1201. PubMed ID: 29112657
[TBL] [Abstract][Full Text] [Related]
3. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation.
Viguera AC; Whitfield T; Baldessarini RJ; Newport DJ; Stowe Z; Reminick A; Zurick A; Cohen LS
Am J Psychiatry; 2007 Dec; 164(12):1817-24; quiz 1923. PubMed ID: 18056236
[TBL] [Abstract][Full Text] [Related]
4. Lithium Use in Pregnancy and the Risk of Cardiac Malformations.
Patorno E; Huybrechts KF; Bateman BT; Cohen JM; Desai RJ; Mogun H; Cohen LS; Hernandez-Diaz S
N Engl J Med; 2017 Jun; 376(23):2245-2254. PubMed ID: 28591541
[TBL] [Abstract][Full Text] [Related]
5. Combining lithium and anticonvulsants in bipolar disorder: a review.
Pies R
Ann Clin Psychiatry; 2002 Dec; 14(4):223-32. PubMed ID: 12630658
[TBL] [Abstract][Full Text] [Related]
6. Mood stabilizers during breastfeeding: a review.
Chaudron LH; Jefferson JW
J Clin Psychiatry; 2000 Feb; 61(2):79-90. PubMed ID: 10732654
[TBL] [Abstract][Full Text] [Related]
7. [Mode of conception, acompanying medical disorders and complications in the second half of pregnancy in women over the age of 35].
Dakov T; Dimitrova V; Maseva A; Todorov T
Akush Ginekol (Sofiia); 2014; 53(8):4-11. PubMed ID: 25672082
[TBL] [Abstract][Full Text] [Related]
8. Mood stabilizers in pregnancy: a systematic review.
Galbally M; Roberts M; Buist A;
Aust N Z J Psychiatry; 2010 Nov; 44(11):967-77. PubMed ID: 21034180
[TBL] [Abstract][Full Text] [Related]
9. Ischemic Placental Disease, Preterm Delivery, and Their Association With Opioid Use During Pregnancy.
Esposito DB; Bateman B; Werler M; Straub L; Mogun H; Hernandez-Diaz S; Huybrechts K
Am J Epidemiol; 2022 Mar; 191(5):759-768. PubMed ID: 34165143
[TBL] [Abstract][Full Text] [Related]
10. Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations.
Holmes LB; Mittendorf R; Shen A; Smith CR; Hernandez-Diaz S
Arch Neurol; 2011 Oct; 68(10):1275-81. PubMed ID: 21670385
[TBL] [Abstract][Full Text] [Related]
11. Doppler sonography of uterine arteries at 20-23 weeks: depth of notch gives information on probability of adverse pregnancy outcome and degree of fetal growth restriction in a low-risk population.
Becker R; Vonk R
Fetal Diagn Ther; 2010; 27(2):78-86. PubMed ID: 20093804
[TBL] [Abstract][Full Text] [Related]
12. Crack abuse during pregnancy: maternal, fetal and neonatal complication.
Aghamohammadi A; Zafari M
J Matern Fetal Neonatal Med; 2016 Mar; 29(5):795-7. PubMed ID: 25747949
[TBL] [Abstract][Full Text] [Related]
13. Neonatal and maternal outcome after blastocyst transfer: a population-based registry study.
Ginström Ernstad E; Bergh C; Khatibi A; Källén KB; Westlander G; Nilsson S; Wennerholm UB
Am J Obstet Gynecol; 2016 Mar; 214(3):378.e1-378.e10. PubMed ID: 26928152
[TBL] [Abstract][Full Text] [Related]
14. Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: population based cohort study.
Bodén R; Lundgren M; Brandt L; Reutfors J; Andersen M; Kieler H
BMJ; 2012 Nov; 345():e7085. PubMed ID: 23137820
[TBL] [Abstract][Full Text] [Related]
15. The role of confounding in the association between pregnancy complications and subsequent preterm birth: a cohort study.
Dunne J; Tessema GA; Pereira G
BJOG; 2022 May; 129(6):890-899. PubMed ID: 34773346
[TBL] [Abstract][Full Text] [Related]
16. Population-based estimate of sibling risk for preterm birth, preterm premature rupture of membranes, placental abruption and pre-eclampsia.
Plunkett J; Borecki I; Morgan T; Stamilio D; Muglia LJ
BMC Genet; 2008 Jul; 9():44. PubMed ID: 18611258
[TBL] [Abstract][Full Text] [Related]
17. Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study.
Huybrechts KF; Bateman BT; Pawar A; Bessette LG; Mogun H; Levin R; Li H; Motsko S; Scantamburlo Fernandes MF; Upadhyaya HP; Hernandez-Diaz S
BMJ; 2020 Feb; 368():m237. PubMed ID: 32075794
[TBL] [Abstract][Full Text] [Related]
18. Decreased PAPP-A is associated with preeclampsia, premature delivery and small for gestational age infants but not with placental abruption.
Ranta JK; Raatikainen K; Romppanen J; Pulkki K; Heinonen S
Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):48-52. PubMed ID: 21482016
[TBL] [Abstract][Full Text] [Related]
19. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
Munch G; Godart N
Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
[TBL] [Abstract][Full Text] [Related]
20. Management of adverse effects of mood stabilizers.
Murru A; Popovic D; Pacchiarotti I; Hidalgo D; León-Caballero J; Vieta E
Curr Psychiatry Rep; 2015 Aug; 17(8):603. PubMed ID: 26084665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]